Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,073 public trials 1,365 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Active, Not Recruiting

Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer

NCT05276973

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +32 more
Locations
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
  • Augusta University Medical Center Augusta, Georgia, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Active, Not Recruiting

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

NCT02955940

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +25 more
Locations
  • UCLA Healthcare Hematology-Oncology Santa Monica, California, United States
  • University of Louisville Louisville, Kentucky, United States
  • New York Oncology Hematology Pc. Clifton Park, New York, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details
Active, Not Recruiting

A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients

NCT06682572

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Kurume University Hospital Kurume, Fukuoka, Japan
  • Mie University Hospital Tsu, Mie-ken, Japan
  • Tohoku University Hospital Sendai, Miyagi, Japan
View Trial Details
Active, Not Recruiting

A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors

NCT04396821

Conditions
Advanced Cancer, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • Yale University New Haven, Connecticut, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

NCT04390399

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • Hoag memorial Presbyterian Hospital Newport Beach, California, United States
  • Astera Cancer Care East Brunswick, New Jersey, United States
  • Avera Cancer Institute Sioux Falls, South Dakota, United States
View Trial Details
Active, Not Recruiting

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

NCT05539430

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +16 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • John Theurer Cancer Center at HackensackUMC Hackensack, New Jersey, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Active, Not Recruiting

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

NCT01844986

Conditions
Adnexal Diseases, Advanced Ovarian Cancer, BRCA Mutation, +24 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Providence Cancer Center Anchorage, Alaska, United States
  • St. Joseph's Hospital & Medical Center Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 177 locations
View Trial Details

Related conditions